NCT01179542

Brief Summary

The involvement of eukaryotic translation initiation factor 4E (eIF4E) in human placental implantation and in the pathological pregnancies: preeclampsia and IUGR.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2010

Typical duration for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 11, 2010

Completed
21 days until next milestone

Study Start

First participant enrolled

September 1, 2010

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

September 13, 2017

Status Verified

August 1, 2010

Enrollment Period

2.1 years

First QC Date

August 10, 2010

Last Update Submit

September 12, 2017

Conditions

PregnancyPreeclampsia

Keywords

iugr pet eIF4E Translation Initiation Factor4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

Outcome Measures

Primary Outcomes (1)

  • measure the Translation Initiation effect of experimental variables observational studies

    2 years

Study Arms (4)

first trimester

first trimester

third trimester

third trimester

prgnancies complicated with IUGR

prgnancies complicated with IUGR

preeclampsia

preeclampsia

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Only the Placenta aftr delivery or abortion

You may qualify if:

  • post TOP or DELIVERY

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pre-EclampsiaFetal Growth Retardation

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesFetal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2010

First Posted

August 11, 2010

Study Start

September 1, 2010

Primary Completion

October 1, 2012

Study Completion

October 1, 2012

Last Updated

September 13, 2017

Record last verified: 2010-08